Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burger

Showing results (671-680 of 1,123) with videos related to

Pageof 113
Sort By:
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
Hearing Research|September 9, 2000
Latency as a function of intensity in auditory neurons: influences of central processingA Klug, A Khan, R M Burger, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2019
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokineticsFloor J E Lubberman, Guillemette E Benoist, Winald Gerritsen, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistatE J Smolders, E P H Colbers, C T M M de Kanter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2001
Indinavir crystallization around the loop of Henle: experimental evidenceJ P Dieleman, S Salahuddin, Y S Hsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of a once-daily indinavir/ritonavir regimenP W Hugen, D M Burger, H J ter Hofstede, et al.
Current Opinion in Pharmacology|July 29, 2015
Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practiceVincent J C Lempers, Lisa C Martial, Michiel F Schreuder, et al.
Aktuelle Urologie|December 14, 2017
[Management of penile cancer patients: new aspects of a rare tumour entity]M Roiner, O Maurer, S Lebentrau, et al.
Science Advances|December 1, 2023
Nanoplankton: The dominant vector for carbon export across the Atlantic Southern Ocean in springRaquel F Flynn, Lumi Haraguchi, Jeff McQuaid, et al.
Pageof 113

Showing results (671-680 of 1,123) with videos related to

Sort By:
Pageof 113
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
Hearing Research|September 9, 2000
Latency as a function of intensity in auditory neurons: influences of central processingA Klug, A Khan, R M Burger, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2019
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokineticsFloor J E Lubberman, Guillemette E Benoist, Winald Gerritsen, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistatE J Smolders, E P H Colbers, C T M M de Kanter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2001
Indinavir crystallization around the loop of Henle: experimental evidenceJ P Dieleman, S Salahuddin, Y S Hsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of a once-daily indinavir/ritonavir regimenP W Hugen, D M Burger, H J ter Hofstede, et al.
Current Opinion in Pharmacology|July 29, 2015
Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practiceVincent J C Lempers, Lisa C Martial, Michiel F Schreuder, et al.
Aktuelle Urologie|December 14, 2017
[Management of penile cancer patients: new aspects of a rare tumour entity]M Roiner, O Maurer, S Lebentrau, et al.
Science Advances|December 1, 2023
Nanoplankton: The dominant vector for carbon export across the Atlantic Southern Ocean in springRaquel F Flynn, Lumi Haraguchi, Jeff McQuaid, et al.
Pageof 113